| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735433A Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 02/15/2006 | CN1735432A Composition for vaccination |
| 02/15/2006 | CN1735431A Whole bacterial cells as immune modulator |
| 02/15/2006 | CN1735430A 免疫原性组合物 Immunogenic composition |
| 02/15/2006 | CN1735429A Coccidial vaccine and methods of making and using same |
| 02/15/2006 | CN1735346A Cell separation compositions methods |
| 02/15/2006 | CN1733922A Super antigen fusion protein and its application method |
| 02/15/2006 | CN1733912A Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1733299A Process for preparing allergoid sublingual buccal vaccine using chitosan as adjuvant |
| 02/15/2006 | CN1242065C Pig breeding and respiratory syndrome recombinant adenovirus and vaccine |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 02/15/2006 | CN1241937C Polyvalent pneumococcal polysaccharide combination vaccine |
| 02/15/2006 | CN1241646C Improvement in or relating to endometrial function |
| 02/15/2006 | CN1241644C Vaccine formulation potentiated by combination of DNA and an antigen |
| 02/15/2006 | CN1241643C Novel pestilence DNA vaccine and its construction and application |
| 02/15/2006 | CN1241642C Novel pestilence DNA vaccine and its usage |
| 02/15/2006 | CN1241641C Toxoplasma body, rubella, giant cell, herpes-I and-II virs antigen purifying technique |
| 02/15/2006 | CN1241640C Genetically engineered pylorospirobacillus vaccine |
| 02/15/2006 | CN1241639C Vaccine composition against malaria |
| 02/15/2006 | CN1241636C Treatment of epidermlyosis bullosa with thymosin Beta-4 |
| 02/15/2006 | CN1241631C Medicine for treating bronchodilatation |
| 02/14/2006 | US6998252 vaccinia virus modified by insertion of chimeric gene containing vaccinia regulatory sequences or DNA sequences functionally equivalent thereto flanking DNA sequences which to nature are not contiguous with flanking vaccinia regulatory dna sequence |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998238 Method for determining MIF content |
| 02/14/2006 | US6998137 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/14/2006 | US6998127 immunogens; for protection from eimeria strains in chickens; attenuated from eimeria strains/sporulated oocysts |
| 02/14/2006 | US6998126 Generating immunogenic oocysts for a vaccine against Coccidiosis. |
| 02/14/2006 | US6998125 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
| 02/14/2006 | US6998124 Erythropoietin receptor antibodies |
| 02/14/2006 | US6998123 interleukins (IL-11); fibronectins; glycoproteins |
| 02/14/2006 | US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides |
| 02/14/2006 | US6998110 High speed absorption; mixture of aqueous polar solvent, propellant, active material and flavor |
| 02/14/2006 | US6998108 Antibodies to p30 polypeptides and methods making and using same |
| 02/14/2006 | US6998106 Radioconjugation of internalizing antibodies |
| 02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/10/2006 | CA2504451A1 Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| 02/09/2006 | WO2006014965A2 Pharmaceutical formulation and process |
| 02/09/2006 | WO2006014953A2 Method for treatment or prophylaxis of a infection using either an antibody which binds to il-9 or an agent which stimulates production of autoantibodies to interleukin-9 |
| 02/09/2006 | WO2006014907A2 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders |
| 02/09/2006 | WO2006014903A2 Compositions and methods of use for adam12 antagonists in treating disease |
| 02/09/2006 | WO2006014726A2 Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 02/09/2006 | WO2006014683A2 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 02/09/2006 | WO2006014673A2 Insulin-oligomer conjugates, formulations and uses thereof |
| 02/09/2006 | WO2006014653A1 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 02/09/2006 | WO2006014579A2 Enhancing class i antigen presentation with synthetic sequences |
| 02/09/2006 | WO2006014505A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/09/2006 | WO2006014335A2 Compositions and methods for treatment of non-hodgkin’s lymphoma |
| 02/09/2006 | WO2006014292A2 Oral vaccine for borrelia |
| 02/09/2006 | WO2006014234A2 Novel recombinant poxvirus composition and uses thereof |
| 02/09/2006 | WO2006014121A1 Muscular dystonia treatment preparation produced from clostridium botulinum culture toxin and method for the production thereof |
| 02/09/2006 | WO2006013904A1 Medicinal composition containing meltrin antagonist |
| 02/09/2006 | WO2006013610A1 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens |
| 02/09/2006 | WO2006013472A2 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | WO2006013336A1 Hpv vaccine comprising peptides from host cell proteins |
| 02/09/2006 | WO2006013013A2 Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) |
| 02/09/2006 | WO2005123129A3 Methods of redistributing apical target antigens to detect and treat cellular proliferative disease |
| 02/09/2006 | WO2005120565A8 Sars vaccines and methods to produce highly potent antibodies |
| 02/09/2006 | WO2005118864A3 Antibodies and related molecules that bind to psca proteins |
| 02/09/2006 | WO2005113786A3 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 02/09/2006 | WO2005113000A3 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 02/09/2006 | WO2005111083A3 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 02/09/2006 | WO2005110479A3 Treatments for pancreatic cancer |
| 02/09/2006 | WO2005103302A3 Mutant viral nucleic acids and vaccine containing same |
| 02/09/2006 | WO2005093425A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 58 (gpr58) |
| 02/09/2006 | WO2005093423A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 02/09/2006 | WO2005070090A3 Regulatory t cells suppress autoimmunity |
| 02/09/2006 | WO2005027825A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/09/2006 | WO2005016381A3 Combination therapy for the treatment and prevention of cancer using epha2, pcdgf, and haah |
| 02/09/2006 | WO2004056983A3 Metalloprotease proteins |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2004002415A3 Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| 02/09/2006 | WO2003105761A3 Immunotoxin as a therapeutic agent and uses thereof |
| 02/09/2006 | WO2003100027A3 Mutant fibronectin and tumor metastasis |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060030695 Platelet-derived growth factor-D; anticarcinogenic agents, angiogenesis inhibition; tissue-targeted therapy; immunoassays; cancer diagnosis |
| 02/09/2006 | US20060030594 Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 02/09/2006 | US20060030536 Combination therapies for cancer and proliferative angiopathies |
| 02/09/2006 | US20060030529 Use of VEGF inhibitors for treatment of eye disorders |
| 02/09/2006 | US20060030524 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 02/09/2006 | US20060030048 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030047 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030027 Capture and removal of biomolecules from body fluids using partial molecular imprints |
| 02/09/2006 | US20060029964 Eating disorders; measuring obesity receptor (ObR) gene expression by detecting mRNA transcripts |
| 02/09/2006 | US20060029932 Method for preventing HIV-1 infection of CD4+ cells |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029655 Method for preparation of vesicles loaded with biological material and different uses thereof |
| 02/09/2006 | US20060029621 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 02/09/2006 | US20060029620 Mycobacterium smegmatis vaccine |
| 02/09/2006 | US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 02/09/2006 | US20060029618 Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria streptococcus sobrinus and streptococcus mutans |
| 02/09/2006 | US20060029617 Porcine circovirus and Helicobacter combination vaccines and methods of use |
| 02/09/2006 | US20060029616 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029612 Prevention and treatment of recurrent respiratory papillomatosis |
| 02/09/2006 | US20060029611 Prevention and treatment of amyloidogenic disease |
| 02/09/2006 | US20060029610 GRP94-based compositions and methods of use thereof |
| 02/09/2006 | US20060029609 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |